Author

Hao-Ran Yue

Institutions: Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University

Observed institutions: Tianjin Medical University Cancer Institute and Hospital, Zhengzhou University, Henan Provincial People's Hospital, Tianjin Medical University

ORCID: 0000-0002-8891-4485

Observed ORCID: 0000-0002-8891-4485

OpenAlex ID: A5069313813

CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling

2023 · Zhao-Hui Chen, Yao Tian, et al. · Breast Cancer Research · 23

PAX5-miR-142 feedback loop promotes breast cancer proliferation by regulating DNMT1 and ZEB1

2023 · Zhao-Hui Chen, Yi-Bo Chen, et al. · Molecular Medicine · 21

HS3ST3A1 and CAPN8 Serve as Immune-Related Biomarkers for Predicting the Prognosis in Thyroid Cancer

2022 · Zhao-Hui Chen, Hao-Ran Yue, et al. · Journal of Oncology · 10

IRX1 suppresses breast cancer progression by inhibiting fatty acid de novo synthesis through downregulating ACACA expression

2026 · Wen-Bo Liu, Lin-Yue Hai, et al. · Cell Death and Disease · 1

HSPA6 Promotes Ferroptosis in Triple-Negative Breast Cancer by Rewiring Lipid Metabolism to Potentiate Membrane Lipid Peroxidation

2026 · Lin-Yue Hai, Zhi-Hao Yu, et al. · International Journal of Biological Sciences · 1

MND1 reduces breast cancer chemosensitivity by promoting RAD51-mediated homologous recombination repair

2026 · Hao-Ran Yue, Zhi-Hao Yu, et al. · Cell Death and Disease

TLR2/NF-κB signaling could oversee the function of CD56bright NK cells in patients afflicted with severe fever and thrombocytopenia syndrome (SFTS)

2025 · Meng-Meng Li, Hao-Ran Yue, et al. · International Immunopharmacology

Works count: 7

Citation count: 56

H-index: 3

I10-index: 3